Total Payments
$360,912
2024 Payments
$37,904
Companies
23
Transactions
592
Medicare Patients
765
Medicare Billing
$137,097
Payment Breakdown by Category
Other$327,606 (90.8%)
Food & Beverage$19,597 (5.4%)
Travel$7,189 (2.0%)
Consulting$6,500 (1.8%)
Education$19.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $327,606 | 120 | 90.8% |
| Food and Beverage | $19,597 | 444 | 5.4% |
| Travel and Lodging | $7,189 | 24 | 2.0% |
| Consulting Fee | $6,500 | 3 | 1.8% |
| Education | $19.99 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $350,054 | 546 | $0 (2024) |
| Madrigal Pharmaceuticals | $8,826 | 8 | $0 (2024) |
| ABBVIE INC. | $375.64 | 8 | $0 (2022) |
| Allergan Inc. | $274.67 | 2 | $0 (2019) |
| Romark Laboratories, LC | $255.99 | 2 | $0 (2019) |
| FUJIFILM Healthcare Americas Corporation | $254.99 | 3 | $0 (2022) |
| PFIZER INC. | $180.82 | 3 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $150.00 | 1 | $0 (2024) |
| Sirtex Medical Inc | $134.49 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $85.07 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,904 | 64 | Gilead Sciences, Inc. ($28,861) |
| 2023 | $27,698 | 74 | Gilead Sciences, Inc. ($27,513) |
| 2022 | $29,516 | 63 | Gilead Sciences, Inc. ($29,339) |
| 2021 | $23,491 | 55 | Gilead Sciences, Inc. ($23,079) |
| 2020 | $16,975 | 43 | Gilead Sciences, Inc. ($16,914) |
| 2019 | $79,038 | 87 | Gilead Sciences, Inc. ($78,627) |
| 2018 | $67,588 | 89 | Gilead Sciences, Inc. ($67,454) |
| 2017 | $78,702 | 117 | Gilead Sciences Inc ($78,267) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.35 | General |
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.24 | General |
| 12/16/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,115.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.88 | General |
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.19 | General |
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,173.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Micro-tech Endoscopy USA, Inc. | Sureclip (Device) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: GI Endoscopy | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,173.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $140.53 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,790.00 | General |
| Category: HCV | ||||||
| 10/29/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: GI | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,790.00 | General |
| Category: HBV | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $121.20 | General |
| Category: HBV | ||||||
| 10/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.16 | General |
| 10/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,790.00 | General |
| Category: HCV | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: HCV | ||||||
| 10/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.02 | General |
| 09/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.72 | General |
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 133 | 144 | $64,250 | $23,277 |
| 2022 | 8 | 216 | 229 | $127,690 | $46,834 |
| 2021 | 8 | 199 | 217 | $87,675 | $34,617 |
| 2020 | 8 | 217 | 235 | $89,030 | $32,369 |
Total Patients
765
Total Services
825
Medicare Billing
$137,097
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 25 | 25 | $23,750 | $8,790 | 37.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 20 | 20 | $20,000 | $5,704 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 30 | $6,750 | $3,252 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 46 | $8,050 | $3,235 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,300 | $1,358 | 41.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,400 | $936.74 | 39.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 29 | 30 | $28,500 | $11,053 | 38.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 20 | 20 | $27,000 | $8,767 | 32.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 23 | 23 | $25,300 | $8,256 | 32.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 23 | 23 | $23,000 | $7,105 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 60 | $12,000 | $5,948 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 38 | $6,650 | $3,050 | 45.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,800 | $1,802 | 47.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $1,440 | $852.76 | 59.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 30 | 31 | $29,450 | $11,572 | 39.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 81 | $12,305 | $5,918 | 48.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 13 | 13 | $17,550 | $5,728 | 32.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Office | 2021 | 17 | 17 | $17,000 | $5,718 | 33.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,900 | $1,871 | 48.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 32 | 35 | $3,500 | $1,796 | 51.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,800 | $1,452 | 51.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,170 | $562.82 | 48.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 38 | 40 | $38,000 | $12,939 | 34.0% |
| 45380 | Biopsy of large bowel using an endoscope | Office | 2020 | 14 | 14 | $15,400 | $5,394 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 83 | $10,790 | $5,001 | 46.3% |
About Dr. Danny Chu, MD
Dr. Danny Chu, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891886842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Chu, MD has received a total of $360,912 in payments from pharmaceutical and medical device companies, with $37,904 received in 2024. These payments were reported across 592 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($327,606).
As a Medicare-enrolled provider, Chu has provided services to 765 Medicare beneficiaries, totaling 825 services with total Medicare billing of $137,097. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 09/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1891886842
Products in Payments
- Vemlidy (Drug) $181,014
- Epclusa (Drug) $102,230
- REZDIFFRA (Drug) $8,752
- Vosevi (Drug) $4,847
- FUJIFILM (Device) $254.99
- XELJANZ (Drug) $180.82
- VOQUEZNA (Drug) $150.00
- VIBERZI (Drug) $142.25
- SIR-Spheres Microspheres (Device) $134.49
- LINZESS (Drug) $132.42
- Alinia (Drug) $129.11
- Alinia Tablets 500mg 30 count bottle (Drug) $126.88
- ENTRESTO (Drug) $85.07
- XIFAXANIBSD (Drug) $78.08
- RESMETIROM (Drug) $74.01
- OCA (Drug) $44.29
- MAVYRET (Drug) $39.42
- ZENPEP (Drug) $36.64
- Mavyret (Drug) $35.49
- SKYRIZI (Biological) $29.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Gastroenterology $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Gastroenterology $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Gastroenterology $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Gastroenterology $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Gastroenterology $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554
Gastroenterology $769,554